Diagnosis and Classification of Pleural Diseases Using Ultrasound Channel Data
Launched by ISRAEL AHARONI · Jun 3, 2020
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to use ultrasound imaging to diagnose and classify pleural diseases, such as pneumothorax (air in the chest cavity) and pleural effusion (fluid around the lungs). The researchers aim to improve the speed and reliability of ultrasound tests by using a new data processing method that requires fewer sensors while still providing clear images. This could make ultrasound a more efficient and effective tool for doctors in diagnosing these conditions.
To participate in this study, eligible individuals include healthy volunteers and those who have been diagnosed with pneumothorax or pleural effusion through previous imaging tests. Participants can expect to undergo an ultrasound exam, either at a medical facility or at their bedside, using a special ultrasound system. The collected information will be analyzed anonymously to help improve future diagnostic methods. If you're interested or think you might qualify, this could be an important opportunity to contribute to advancements in medical technology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy volunteers
- • Volunteers with active Pneumothorax, detected by prior imaging studies up to 24 hours before the ultrasound scan
- • Volunteers with active Pleural effusion, detected by prior imaging studies up to 48 hours before the ultrasound scan ult
- Exclusion Criteria:
- • Volunteers with the aforementioned diagnosis, which was not detected during the actual ultrasound exam
- • Volunteers who expressed their desire to be excluded from the study at any given time point.
About Israel Aharoni
Israel Aharoni is a dedicated clinical trial sponsor specializing in the advancement of innovative therapeutic solutions. With a strong focus on ethical research practices and patient safety, Aharoni leads initiatives that bridge the gap between scientific discovery and clinical application. The organization prioritizes collaboration with healthcare professionals and regulatory bodies to ensure rigorous study designs and adherence to industry standards. Committed to improving health outcomes, Israel Aharoni fosters a culture of excellence and transparency in all clinical trial endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Afula, , Israel
Patients applied
Trial Officials
Israel Israel, M.D. Ph.D
Principal Investigator
Imaging institute, Haemek Medical Center, Afula, Israel.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials